TG Therapeutics, Inc

(NASDAQ:TGTX)

Latest On TG Therapeutics, Inc (TGTX):

Date/Time Type Description Signal Details
2023-05-06 07:44 ESTNewsTG Therapeutics' Stock Surge: Exploring The Factors And Exercising Caution (Rating Upgrade)N/A
2023-05-02 02:37 ESTNewsTG Therapeutics jumps 19% to hit 52-week high after Q1 beat (update)N/A
2023-05-01 14:23 ESTNewsTG Therapeutics GAAP EPS of -$0.28 beats by $0.07, revenue of $7.8M beats by $4.42MN/A
2023-05-01 14:23 ESTNewsTG Therapeutics slips despite Q1 beatN/A
2023-05-01 14:22 ESTNewsTG Therapeutics, Inc. (TGTX) Q1 2023 Earnings Call TranscriptN/A
2023-04-29 00:22 ESTNewsTG Therapeutics: A Plethora Of Good News, Strong Revenues ExpectedN/A
2023-04-27 23:34 ESTNewsTG Therapeutics gains after reimbursement win for multiple sclerosis therapyN/A
2023-04-11 19:18 ESTNewsTG Therapeutics extends rally to hit 52-week high after B. Riley commentsN/A
2023-04-11 19:18 ESTNewsHot Stocks: TLRY drops on earnings; MARA, MSTR, RIOT, COIN boosted by crypto rise; PSMT gains; MRNA fallsN/A
2023-04-11 04:01 ESTNewsTG Therapeutics jumps 22% as Cantor cites strong Briumvi salesN/A
2023-03-31 11:03 ESTNewsTG Therapeutics' multiple sclerosis drug Briumvi gets EMA panel backingN/A
2023-03-22 17:59 ESTNewsTG Therapeutics' Briumvi Has Potential For Growth In A Crowded MarketN/A
2023-03-20 19:43 ESTNewsTG Therapeutics: That ICER Report Doesn't Bother MeN/A
2023-03-09 23:16 ESTNewsTG Therapeutics’ price for multiple sclerosis therapy is not low enough - ICERN/A
2023-03-01 01:53 ESTNewsTG Therapeutics, Inc. (TGTX) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 10:24 ESTNewsTG Therapeutics GAAP EPS of -$0.39 misses by $0.14, revenue of $0.08M misses by $1.52MN/A
2023-02-27 20:17 ESTNewsTG Therapeutics Q4 2022 Earnings PreviewN/A
2023-02-23 20:12 ESTNewsTG Therapeutics' Briumvi: A Tough Sell For Multiple Sclerosis Treatment MarketN/A
2023-02-07 11:09 ESTNewsTG Therapeutics up as Cantor sees a “strong launch” for multiple sclerosis therapyN/A
2023-02-01 21:47 ESTNewsTG Therapeutics: Strategy After Briumvi LaunchN/A
2023-01-26 12:41 ESTNewsTG Therapeutics launches newly approved multiple sclerosis therapyN/A
2023-01-11 14:59 ESTNewsTG Therapeutics adds 10% to extend gains after insider purchaseN/A
2023-01-02 17:51 ESTNewsTG Therapeutics: Ramifications Of Briumvi ApprovalN/A
2022-12-29 23:50 ESTNewsTG Therapeutics surges as focus turns to launch of new multiple sclerosis therapyN/A
2022-12-28 18:27 ESTNewsTG Therapeutics jumps 19% as FDA approves multiple sclerosis therapyN/A
2022-12-24 22:09 ESTNewsStocks To Watch: Nio, Tesla And Hopes For A Santa Clause RallyN/A
2022-12-17 21:07 ESTNewsIt's almost 2023, but here are the drugs the FDA could approve before the end of the yearN/A
2022-12-15 16:42 ESTNewsTG Therapeutics: Ublituximab Could Achieve $1 Billion In Annual Sales By Year-End 2024N/A
2022-12-14 23:31 ESTNewsTG Therapeutics: Would Santa Deliver An Early Present?N/A
2022-11-13 05:29 ESTNewsTG Therapeutics (TGTX) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 23:59 ESTNewsTG Therapeutics GAAP EPS of -$0.26 beats by $0.07, revenue of $0.09M misses by $1.61MN/A
2022-11-10 23:59 ESTNewsTG Therapeutics jumps 56% amid FDA labeling talks for multiple sclerosis therapyN/A
2022-10-09 13:35 ESTNewsTG Therapeutics: Elucidating The Upcoming BinaryN/A
2022-09-21 15:15 ESTNewsTG Therapeutics: We Are Just Hanging In ThereN/A
2022-08-25 19:03 ESTNewsTG Therapeutics announces peer-reviewed publication of multiple sclerosis phase 3 trialsN/A
2022-08-09 08:40 ESTNewsTG Therapeutics stock soars 18% on Q2 beat as net loss narrows; eyes MS drug win by year-endN/A
2022-08-09 08:40 ESTNewsTG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 09:01 ESTNewsTG Therapeutics GAAP EPS of -$0.30 beats by $0.17, revenue of $0.6M beats by $0.42MN/A
2022-08-06 00:27 ESTNewsTG Therapeutics Q2 2022 Earnings PreviewN/A
2022-07-09 02:04 ESTNewsTG Therapeutics And Ublituximab: From Icing To LifelineN/A
2022-06-01 21:32 ESTNewsTG Therapeutics slips as FDA withdraws approval for cancer drugN/A
2022-05-31 12:26 ESTNewsTG Therapeutics announces delay in FDA review for multiple sclerosis drugN/A
2022-05-21 18:22 ESTNewsTG Therapeutics initiated at BofA with a bearish view on multiple sclerosis drugN/A
2022-04-22 18:32 ESTNewsTG Therapeutics: Can The Company Successfully Turn Around?N/A
2022-04-18 21:06 ESTNewsTG Therapeutics: I May Double Down AgainN/A
2022-04-18 21:06 ESTNewsTG Therapeutics extends losses as H.C. Wainwright slashes target on Ukoniq setbackN/A
2022-04-18 06:43 ESTNewsTG Therapeutics stock falls 24% as it withdraws Ukoniq from sale, pulls filing with FDAN/A
2022-03-03 18:32 ESTNewsTG Therapeutics stock falls as FDA extends review of blood cancer drug comboN/A
2022-03-01 13:48 ESTNewsTG Therapeutics GAAP EPS of -$0.70 misses by $0.08, revenue of $2.32M beats by $0.08MN/A
2022-03-01 13:47 ESTNewsTG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q4 2021 Results - Earnings Call TranscriptN/A

About TG Therapeutics, Inc (TGTX):

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbralisib, an oral inhibitor of PI3K-delta and CK1-epsilon for the treatment of CLL, marginal zone lymphoma, and follicular lymphoma. The company also develops Cosibelimab, a human monoclonal antibody of IgG1 subtype that binds to programmed death-ligand 1 (PD-L1) and blocks its interactions with PD-1 and B7.1 receptors; TG-1701 is an orally available and covalently-bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK compared to ibrutinib in in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. In addition, it has various licensed preclinical programs for BET, interleukin-1 receptor associated kinase-4, and GITR; and collaboration agreements with Checkpoint Therapeutics, Inc., Jiangsu Hengrui Medicine Co., Novimmune SA, Ligand Pharmaceuticals Incorporated, and Jubilant Biosys. The company has strategic alliances with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Rhizen Pharmaceuticals, S A. The company is headquartered in New York, New York.

TGTX Quotes by TradingView

See Advanced Chart

General

  • Name TG Therapeutics, Inc
  • Symbol TGTX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 272
  • Last Split Factor100:5625
  • Last Split Date2012-04-30
  • Fiscal Year EndDecember
  • IPO Date1995-12-14
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.tgtherapeutics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 36580.51
  • Price/Book (Most Recent Quarter) 13.05
  • Enterprise Value Revenue 40882.96
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.06
  • Next Year EPS Estimate -$0.80
  • Next Quarter EPS Estimate -$0.50
  • Operating Margin -179996%
  • Return on Assets -43%
  • Return on Equity -100%
  • Revenue 152000
  • Earnings Per Share -$1.96
  • Revenue Per Share $0
  • Gross Profit 152000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 6.47 billion
  • EBITDA -158616992
  • PE Ratio 37.85
  • Analyst Target Price $75.33
  • Book Value Per Share $4.00
View More

Share Statistics

  • Shares Outstanding 137.81 million
  • Shares Float 120.36 million
  • % Held by Insiders 713%
  • % Held by Institutions 67.24%
  • Shares Short 11.84 million
  • Shares Short Prior Month 11.76 million
  • Short Ratio 8
  • Short % of Float 10%
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 2.13
  • 52 Week High $56.74
  • 52 Week Low $7.12
  • 50 Day Moving Average 46.97
  • 200 Day Moving Average 37.82
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

TG Therapeutics, Inc (TGTX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

TG Therapeutics, Inc (TGTX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$38000-$0.72-$0.58-23.78%
2020-09-302020-11-09$N/A-$0.73-$0.41-76.76%
2020-06-302020-08-10$N/A-$0.47-$0.34-39.05%
2020-03-312020-05-11$38000-$0.48-$0.36-34.08%
2019-12-312020-03-02$38000-$0.44-$0.42-5.39%
2019-09-302019-11-12$38000-$0.69-$0.34-104.44%
2019-06-302019-08-09$38000-$0.42-$0.444.55%
2019-03-312019-05-10$38000-$0.43-$0.441.15%
2018-12-312019-03-01$38000-$0.69-$0.44-55.41%
2018-09-302018-11-09$38000-$0.43-$0.5420.37%
2018-06-302018-08-07$38000-$0.59-$0.53-12.38%
2018-03-312018-05-08$38000-$0.59-$0.44-34.09%
2017-12-312018-03-08$38000-$0.46-$0.44-4.14%
2017-09-302017-11-08$38000-$0.48-$0.43-11.63%
2017-06-302017-08-09$38000-$0.45-$0.43-5.26%
2017-03-312017-05-05$38000-$0.52-$0.41-27.45%
2016-12-312017-03-10$38000-$0.48-$0.36-33.33%
2016-09-302016-11-07$38000-$0.50-$0.31-61.29%
2016-06-302016-08-08$38000-$0.33-$0.29-15.79%
2016-03-312016-05-10$38000-$0.28-$0.3621.5%
2015-12-312016-03-07$38000-$0.37-$0.32-16.83%
2015-09-302015-11-09$38000-$0.28-$0.3417.65%
2015-06-302015-08-10$38000-$0.38-$0.30-26.67%
2015-03-312015-05-04$38000-$0.39-$0.33-18.18%
2014-12-312015-03-11$38000-$0.48-$0.26-84.62%
2014-09-302014-11-10$38000-$0.51-$0.32-59.38%
2014-06-302014-07-21$38000-$0.32-$0.24-33.33%
2014-03-312014-05-12$38000-$0.25-$0.18-38.89%
2013-12-312014-03-05$38000-$0.19-$0.17-11.76%
2013-09-302013-11-11$38000-$0.16-$0.2227.27%
2013-06-302013-08-01$38000-$0.29-$0.16-81.25%
2013-03-312013-05-14$38000-$0.17-$0.15-13.33%
2012-12-312013-03-12$19000-$0.12-$0.137.69%
2012-09-302012-11-08$N/A-$0.16-$0.12-33.33%
2012-06-302012-08-09$N/A-$0.16-$0.06-166.67%
2012-03-312012-05-21$N/A-$2.03
2011-09-302011-11-14$N/A-$9.05
2011-06-302011-08-15$N/A-$64.63
2011-03-312011-05-23$N/A$84.58
2010-12-312011-03-02$N/A$9.18
2010-09-302010-11-15$N/A$0.96
2010-06-302010-08-16$N/A$43.21
2010-03-312010-05-24$N/A-$54.27
2009-12-312010-03-03$N/A-$8.88
2009-09-302009-11-16$N/A-$16.57
2009-06-302009-08-14$N/A-$55.45
2009-03-312009-05-19$N/A-$30.34
2008-12-312009-02-25$N/A$5.06
2008-09-302008-12-03$N/A-$55.53
2008-06-302008-08-19$N/A-$56.64
2008-03-312008-05-20$N/A-$62.10
2007-09-302007-11-14$N/A-$112.50-$28.12-300.07%
2007-06-302007-07-09$N/A-$112.50-$84.37-33.34%
2007-03-312007-05-15$N/A-$119.73
2006-09-302006-11-14$N/A-$84.37-$84.370%
2006-06-302006-08-14$N/A-$112.50-$112.500%
2006-03-312006-05-15$N/A-$140.62-$140.620%
2005-09-302005-09-30$N/A-$118.85
2005-06-302005-06-30$N/A-$934.25
2005-03-312005-03-31$N/A-$152.43
2004-12-312004-12-31$N/A-$196.87
2004-09-302004-09-30$N/A-$240.39
2004-06-302004-06-30$N/A-$109.61
2004-03-312004-03-31$N/A-$140.65
2003-12-312003-12-31$N/A-$225.00
2003-09-302003-09-30$N/A-$391.61
2003-06-302003-06-30$N/A-$93.46
2003-03-312003-03-31$N/A-$91.67
2002-09-302002-09-30$N/A-$507.41
2002-06-302002-06-30$N/A$24.21
2002-03-312002-03-31$N/A-$552.10
2001-09-302001-09-30$N/A-$1,528.45
2001-06-302001-06-30$-2712000-$4,513.55
2001-03-312001-03-31$2.71 million$1,855.58
2000-09-302000-09-30$1.07 million-$2,621.34
2000-06-302000-06-30$1.44 million-$7,888.48
2000-03-312000-03-31$925000-$5,766.57
1999-09-301999-09-30-$986.48
1999-06-301999-06-30-$1,929.43
1999-03-311999-03-31-$2,666.06
1998-09-301998-09-30-$5,140.91
1998-06-301998-06-30$695.14
1998-03-311998-03-31-$9,885.89

TG Therapeutics, Inc (TGTX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

TG Therapeutics, Inc (TGTX) Chart:

TG Therapeutics, Inc (TGTX) News:

Below you will find a list of latest news for TG Therapeutics, Inc (TGTX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

TG Therapeutics, Inc (TGTX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-05-15150CALL0 0788.56TRUE00
2026-05-152021.4CALL0 34477.63TRUE00
2026-05-152319.21CALL0 143352.83TRUE00
2026-05-152418.3CALL0 54214.08TRUE00
2026-05-152517.4CALL0 343309.95TRUE00
2026-05-152617.75CALL0 307328.98TRUE00
2026-05-152716.15CALL2 30398.69TRUE16.150
2026-05-152815.3CALL102 112224.87TRUE1.510.11
2026-05-152913.7CALL4 55251.14TRUE0.260.02
2026-05-153012.79CALL6 704256.6TRUE0.260.02
2026-05-153111.7CALL3 473213.9TRUE0.950.09
2026-05-153211.4CALL14 898311.87TRUE1.20.12
2026-05-153310.43CALL15 123200.57TRUE10.430
2026-05-15349.5CALL22 360181.85TRUE9.50
2026-05-15358.36CALL10 1899236.36TRUE1.160.16
2026-05-15367.45CALL3 754101.51TRUE0.550.08
2026-05-15375.6CALL8 106887.37TRUE0.10.02
2026-05-15384.9CALL77 478121.36TRUE00
2026-05-15394.18CALL7 537128.94TRUE0.580.16
2026-05-15403.2CALL104 1737108.16TRUE-0.1-0.03
2026-05-15411.81CALL2 57553.46TRUE-0.44-0.2
2026-05-15422CALL16 93560.36TRUE0.650.48
2026-05-15430.66CALL96 67455.95FALSE-0.09-0.12
2026-05-15440.35CALL571 39457.09FALSE-0.24-0.41
2026-05-15450.33CALL36 286058.6FALSE0.030.1
2026-05-15460.53CALL0 182.02FALSE00
2026-05-15470.2CALL2 12590.39FALSE0.20
2026-05-15480CALL0 0189.14FALSE00
2026-05-15490.1CALL111 098.64FALSE0.10
2026-05-15500.05CALL6 184095.97FALSE-0.05-0.5
2026-05-15550.05CALL18 963140.37FALSE0.050
2026-05-15600.05CALL0 7344.63FALSE00
2026-05-15150PUT0 13938.18FALSE00
2026-05-15200PUT0 488709.93FALSE00
2026-05-15230PUT0 80600.66FALSE00
2026-05-15240PUT0 95329.42FALSE00
2026-05-15250.05PUT0 191535.48FALSE00
2026-05-15260.1PUT0 205288.6FALSE00
2026-05-15270PUT0 3860444.78FALSE00
2026-05-15280.08PUT0 3791324.17FALSE00
2026-05-15290.34PUT0 3145242.05FALSE00
2026-05-15300.03PUT2 1561177.19FALSE0.030
2026-05-15310.05PUT0 291158.34FALSE00
2026-05-15320.05PUT0 328144.24FALSE00
2026-05-15330.05PUT0 359130.47FALSE00
2026-05-15340.02PUT1 520113.32FALSE0.020
2026-05-15350.08PUT0 222116FALSE00
2026-05-15360.38PUT0 58163.39FALSE00
2026-05-15370.1PUT0 239115.45FALSE00
2026-05-15380.2PUT0 132109.12FALSE00
2026-05-15390.18PUT0 1993.8FALSE00
2026-05-15400.09PUT2 9252.58FALSE-0.14-0.61
2026-05-15410.5PUT0 6545.72FALSE00
2026-05-15420.5PUT0 8741.75FALSE00
2026-05-15430.75PUT1 27831.9TRUE0.750
2026-05-15440PUT0 093.53TRUE00
2026-05-15452.1PUT10 00TRUE2.10
2026-05-15460PUT0 00TRUE00
2026-05-15470PUT0 00TRUE00
2026-05-15480PUT0 0110.36TRUE00
2026-05-15490PUT0 00TRUE00
2026-05-15500PUT0 00TRUE00
2026-05-15550PUT0 00TRUE00
2026-05-15600PUT0 00TRUE00
2026-06-18200CALL0 00TRUE00
2026-06-182517CALL0 50TRUE00
2026-06-18260CALL0 095.27TRUE00
2026-06-18270CALL0 8114.61TRUE00
2026-06-182812.76CALL0 6102.03TRUE00
2026-06-18297CALL0 5100.02TRUE00
2026-06-183014.63CALL0 1595.27TRUE00
2026-06-18310CALL0 094.41TRUE00
2026-06-183211.65CALL11 294.5TRUE11.650
2026-06-183310.35CALL0 1376.93TRUE00
2026-06-183410.8CALL0 5060.92TRUE00
2026-06-18357.6CALL0 30365.56TRUE00
2026-06-18368.59CALL0 6162.08TRUE00
2026-06-18375.73CALL0 14749.72TRUE00
2026-06-18386.2CALL0 14253.95TRUE00
2026-06-18395.2CALL0 20460.44TRUE00
2026-06-18404.4CALL21 154854.69TRUE00
2026-06-18413.86CALL5 12655.53TRUE3.860
2026-06-18422.91CALL12 16747.57TRUE0.610.27
2026-06-18432.4CALL3 32247.02FALSE0.010
2026-06-18441.9CALL142 7945.53FALSE-0.85-0.31
2026-06-18451.48CALL59 64444.35FALSE-0.22-0.13
2026-06-18461.5CALL4 050.82FALSE1.50
2026-06-18470.86CALL0 744.23FALSE00
2026-06-18481.08CALL145 5552.62FALSE1.080
2026-06-18491.1CALL0 547.42FALSE00
2026-06-18500.5CALL74 180646.53FALSE-0.1-0.17
2026-06-18550.25CALL9 32653.59FALSE0.050.25
2026-06-18600.1CALL0 36098.94FALSE00
2026-06-18200PUT0 0170.94FALSE00
2026-06-18250PUT0 0134.75FALSE00
2026-06-18260PUT0 0139.99FALSE00
2026-06-18270PUT0 280.25FALSE00
2026-06-18280PUT0 0106.84FALSE00
2026-06-18290.05PUT0 3771.88FALSE00
2026-06-18300.12PUT0 3980.43FALSE00
2026-06-18310.41PUT0 1163.35FALSE00
2026-06-18321.16PUT0 659.89FALSE00
2026-06-18330.2PUT0 7156.21FALSE00
2026-06-18340.23PUT0 13751FALSE00
2026-06-18350.3PUT0 7650.6FALSE00
2026-06-18360.4PUT10 9048.1FALSE0.40
2026-06-18370.53PUT0 234448.2FALSE00
2026-06-18380.8PUT0 12446.98FALSE00
2026-06-18390PUT0 047.12FALSE00
2026-06-18401.3PUT35 4345.99FALSE-0.2-0.13
2026-06-18411.7PUT0 743.78FALSE00
2026-06-18422.1PUT0 15744.3FALSE00
2026-06-18432.65PUT0 956.98TRUE00
2026-06-18440PUT0 041.07TRUE00
2026-06-18453.7PUT0 740.56TRUE00
2026-06-18460PUT0 039.19TRUE00
2026-06-18470PUT0 044.42TRUE00
2026-06-18480PUT0 044.46TRUE00
2026-06-18490PUT0 055.14TRUE00
2026-06-18500PUT0 048.83TRUE00
2026-06-18550PUT0 00TRUE00
2026-06-18600PUT0 059.79TRUE00
2026-08-211528.2CALL0 7271.94TRUE00
2026-08-212019.4CALL0 2079.36TRUE00
2026-08-21210CALL0 0103.55TRUE00
2026-08-212217.4CALL0 73101.18TRUE00
2026-08-212321CALL2 5109.32TRUE210
2026-08-212416.5CALL0 089.61TRUE00
2026-08-212516.96CALL0 8382.59TRUE00
2026-08-21260CALL0 15183.42TRUE00
2026-08-21270CALL0 4880.91TRUE00
2026-08-21280CALL0 3275.81TRUE00
2026-08-21290CALL0 4477.8TRUE00
2026-08-213014.1CALL10 8872.73TRUE14.10
2026-08-21310CALL0 1671.8TRUE00
2026-08-21320CALL0 5150.08TRUE00
2026-08-213312.45CALL0 1164.66TRUE00
2026-08-21347.9CALL0 1963.13TRUE00
2026-08-213510CALL13 44163.63TRUE100
2026-08-21366.25CALL0 5754.14TRUE00
2026-08-21378.3CALL0 8251.46TRUE00
2026-08-21387.58CALL0 2652.62TRUE00
2026-08-21394.95CALL0 4257.6TRUE00
2026-08-21406.28CALL5 58954.27TRUE0.550.1
2026-08-21410CALL0 055.93TRUE00
2026-08-21424.9CALL1 1350TRUE0.180.04
2026-08-21435.7CALL0 748.98FALSE00
2026-08-21444.32CALL2 20648.15FALSE4.320
2026-08-21453.8CALL0 64648.62FALSE00
2026-08-21460CALL0 039.62FALSE00
2026-08-21470CALL0 050.48FALSE00
2026-08-21480CALL0 048.46FALSE00
2026-08-21490CALL0 047.8FALSE00
2026-08-21502.12CALL5 79250.15FALSE0.230.12
2026-08-21551.1CALL12 17948.76FALSE1.10
2026-08-21600.55CALL0 750.23FALSE00
2026-08-21150PUT0 78123.56FALSE00
2026-08-21200.18PUT0 67113.54FALSE00
2026-08-21210.32PUT0 1179.98FALSE00
2026-08-21220PUT0 1569.87FALSE00
2026-08-21230PUT0 767.65FALSE00
2026-08-21240.2PUT0 4365.26FALSE00
2026-08-21250.3PUT0 1696.9FALSE00
2026-08-21260.34PUT0 1579.02FALSE00
2026-08-21270PUT0 2164.65FALSE00
2026-08-21280.45PUT0 6658.75FALSE00
2026-08-21290PUT0 1357.34FALSE00
2026-08-21300.62PUT0 4459.07FALSE00
2026-08-21310PUT0 1954.96FALSE00
2026-08-21320PUT0 167.44FALSE00
2026-08-21330PUT0 1164.08FALSE00
2026-08-21341.6PUT0 551.98FALSE00
2026-08-21351.3PUT0 7349.44FALSE00
2026-08-21362.54PUT0 3151.4FALSE00
2026-08-21370PUT0 3751.84FALSE00
2026-08-21380PUT0 054.39FALSE00
2026-08-21390PUT0 2548.98FALSE00
2026-08-21402.62PUT0 6746.6FALSE00
2026-08-21410PUT0 047.46FALSE00
2026-08-21420PUT0 042.95FALSE00
2026-08-21430PUT0 046.61TRUE00
2026-08-21440PUT0 045.27TRUE00
2026-08-21455.6PUT0 3746.33TRUE00
2026-08-21460PUT0 047.58TRUE00
2026-08-21470PUT0 051.95TRUE00
2026-08-21480PUT0 047.9TRUE00
2026-08-21490PUT0 042.49TRUE00
2026-08-21500PUT0 042.11TRUE00
2026-08-21550PUT0 033.15TRUE00
2026-08-21600PUT0 00TRUE00
2026-11-202018.7CALL0 383.91TRUE00
2026-11-20220CALL0 063.78TRUE00
2026-11-20230CALL0 074.47TRUE00
2026-11-20240CALL0 072.17TRUE00
2026-11-20250CALL0 071.81TRUE00
2026-11-20260CALL0 059.47TRUE00
2026-11-20270CALL0 058.64TRUE00
2026-11-20280CALL0 055.74TRUE00
2026-11-20290CALL0 2065.56TRUE00
2026-11-203015.2CALL100 065.6TRUE15.20
2026-11-20310CALL0 063.41TRUE00
2026-11-20320CALL0 056.18TRUE00
2026-11-20330CALL0 560.63TRUE00
2026-11-203410.9CALL0 659.88TRUE00
2026-11-203511.55CALL0 1352.01TRUE00
2026-11-20360CALL0 053.26TRUE00
2026-11-20370CALL0 2153.15TRUE00
2026-11-20380CALL0 652.79TRUE00
2026-11-20390CALL0 056.3TRUE00
2026-11-20408.5CALL7 10457.19TRUE0.510.06
2026-11-20410CALL0 056.1TRUE00
2026-11-20420CALL0 050.64TRUE00
2026-11-20430CALL0 054.3FALSE00
2026-11-20446CALL28 3051.11FALSE60
2026-11-20455.6CALL18 57151.04FALSE0.20.04
2026-11-20466.26CALL0 149.58FALSE00
2026-11-20474.7CALL30 2649.56FALSE0.50.12
2026-11-20484.8CALL42 1553.03FALSE0.70.17
2026-11-20493.8CALL0 31152.29FALSE00
2026-11-20504.1CALL82 18952.2FALSE0.580.16
2026-11-20552.8CALL29 2939.66FALSE2.80
2026-11-20601.75CALL33 049.24FALSE1.750
2026-11-20200PUT0 270.99FALSE00
2026-11-20220PUT0 067.43FALSE00
2026-11-20230.57PUT0 158.97FALSE00
2026-11-20240PUT0 057.18FALSE00
2026-11-20250PUT0 076.75FALSE00
2026-11-20260PUT0 1570.82FALSE00
2026-11-20270PUT0 054.67FALSE00
2026-11-20280PUT0 365.46FALSE00
2026-11-20290PUT0 354.89FALSE00
2026-11-20302.25PUT0 51055.37FALSE00
2026-11-20310PUT0 052.23FALSE00
2026-11-20320PUT0 059.81FALSE00
2026-11-20330PUT0 056.32FALSE00
2026-11-20340PUT0 053.73FALSE00
2026-11-20352.5PUT0 5150.02FALSE00
2026-11-20360PUT0 053.05FALSE00
2026-11-20370PUT0 049.68FALSE00
2026-11-20380PUT0 054.51FALSE00
2026-11-20393.84PUT0 1949.49FALSE00
2026-11-20400PUT0 048.03FALSE00
2026-11-20410PUT0 048.99FALSE00
2026-11-20420PUT0 053.03FALSE00
2026-11-20430PUT0 046.79TRUE00
2026-11-20440PUT0 044.17TRUE00
2026-11-20450PUT0 051.16TRUE00
2026-11-20460PUT0 044.85TRUE00
2026-11-20470PUT0 045.28TRUE00
2026-11-20480PUT0 047.59TRUE00
2026-11-20490PUT0 043.02TRUE00
2026-11-20500PUT0 046.28TRUE00
2026-11-20550PUT0 041.97TRUE00
2026-11-20600PUT0 035.75TRUE00
2027-01-151329.55CALL0 13075.39TRUE00
2027-01-151529.61CALL0 76673.89TRUE00
2027-01-151825.84CALL0 22367.91TRUE00
2027-01-152024.89CALL0 75670.08TRUE00
2027-01-152221.64CALL4 337359.89TRUE0.240.01
2027-01-152519.75CALL30 68269.6TRUE19.750
2027-01-152718.15CALL35 29867.23TRUE0.430.02
2027-01-153015.9CALL1 71355.66TRUE1.60.11
2027-01-153215CALL0 23962.61TRUE00
2027-01-153512.6CALL5 159561.76TRUE12.60
2027-01-15379.8CALL0 68258.12TRUE00
2027-01-15409.42CALL2 304956.63TRUE0.620.07
2027-01-15410CALL0 055.78TRUE00
2027-01-15428.35CALL0 12356.83TRUE00
2027-01-15430CALL0 051.8FALSE00
2027-01-15440CALL0 053.68FALSE00
2027-01-15457CALL2 161654.3FALSE70
2027-01-15460CALL0 053.69FALSE00
2027-01-15476.4CALL1 25555.11FALSE6.40
2027-01-15480CALL0 052.83FALSE00
2027-01-15490CALL0 052.58FALSE00
2027-01-15504.9CALL84 189651.13FALSE0.30.07
2027-01-15554CALL0 92751.21FALSE00
2027-01-15602.65CALL0 182946.49FALSE00
2027-01-15130.15PUT0 4776.58FALSE00
2027-01-15150PUT0 20989.2FALSE00
2027-01-15180.4PUT0 8569.32FALSE00
2027-01-15200.37PUT10 17760.91FALSE0.370
2027-01-15220.8PUT0 32959.72FALSE00
2027-01-15251.05PUT0 223157.13FALSE00
2027-01-15271.74PUT0 12256.23FALSE00
2027-01-15301.72PUT8 104853.65FALSE1.720
2027-01-15322.36PUT0 3253.71FALSE00
2027-01-15353.5PUT0 170454.18FALSE00
2027-01-15374.5PUT0 2550.55FALSE00
2027-01-15405.05PUT10 96949.55FALSE5.050
2027-01-15410PUT0 049.51FALSE00
2027-01-15420PUT0 17851.53FALSE00
2027-01-15430PUT0 052.22TRUE00
2027-01-15440PUT0 048.37TRUE00
2027-01-15450PUT0 28747.32TRUE00
2027-01-15460PUT0 047.91TRUE00
2027-01-15470PUT0 048.71TRUE00
2027-01-15480PUT0 046.83TRUE00
2027-01-15490PUT0 045.88TRUE00
2027-01-155010.4PUT0 32043.26TRUE00
2027-01-15550PUT0 6942.71TRUE00
2027-01-156018.2PUT1 50042.48TRUE18.20
2028-01-211531.25CALL0 76267.38TRUE00
2028-01-212027.11CALL0 14270.56TRUE00
2028-01-212323.7CALL1 15063.44TRUE23.70
2028-01-21250CALL0 23763.44TRUE00
2028-01-212814.8CALL0 2257.23TRUE00
2028-01-213016.75CALL0 15459.7TRUE00
2028-01-21320CALL0 34859.79TRUE00
2028-01-213514.5CALL0 6754.85TRUE00
2028-01-21370CALL0 657.15TRUE00
2028-01-214014.5CALL1 3758.39TRUE14.50
2028-01-214211.5CALL0 8053.61TRUE00
2028-01-214511.31CALL0 98452.83FALSE00
2028-01-215010.5CALL0 30551.66FALSE00
2028-01-21559CALL2 131554.65FALSE0.80.1
2028-01-21607.2CALL0 31955.56FALSE00
2028-01-21150.65PUT3 17259.87FALSE0.650
2028-01-21200PUT0 4858.28FALSE00
2028-01-21232.25PUT15 5257.9FALSE2.250
2028-01-21250PUT0 3865.24FALSE00
2028-01-21284.71PUT0 4063.17FALSE00
2028-01-21304.7PUT3 36557.65FALSE4.70
2028-01-21320PUT0 3458.49FALSE00
2028-01-21356.24PUT0 2158.3FALSE00
2028-01-21370PUT0 355.39FALSE00
2028-01-21400PUT0 2056.85FALSE00
2028-01-21420PUT0 056.07FALSE00
2028-01-214511.83PUT116 12753.71TRUE11.830
2028-01-21500PUT0 22951.02TRUE00
2028-01-215521.1PUT0 1253.76TRUE00
2028-01-21600PUT0 047.34TRUE00

Latest TGTX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST987$4.135
Jun 13, 2022 7:59 PM EST93$4.14
Jun 13, 2022 7:59 PM EST1$4.14
Jun 13, 2022 7:59 PM EST10$4.14
Jun 13, 2022 7:59 PM EST200$4.135

TG Therapeutics, Inc (TGTX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm
2018-07-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1001316/000000000018021923/0000000000-18-021923-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000009375119000238/0000093751-19-000238-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000009375120000475/0000093751-20-000475-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000021545719006548/0000215457-19-006548-index.htm
2019-06-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000021545719008047/0000215457-19-008047-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000031506618001636/0000315066-18-001636-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000031506619001380/0000315066-19-001380-index.htm
2020-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000031506620001583/0000315066-20-001583-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000083423720008183/0000834237-20-008183-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000090266419001008/0000902664-19-001008-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000090266420001111/0000902664-20-001111-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920021910/0001104659-20-021910-index.htm
2020-05-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920058131/0001104659-20-058131-index.htm
2020-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920072021/0001104659-20-072021-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076543/0001104659-20-076543-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076544/0001104659-20-076544-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076545/0001104659-20-076545-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076546/0001104659-20-076546-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076547/0001104659-20-076547-index.htm
2020-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920080593/0001104659-20-080593-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm
2020-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000110465920092406/0001104659-20-092406-index.htm
2020-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920104436/0001104659-20-104436-index.htm
2019-05-31PX14A6GNotice of exempt solicitation submitted by non-managementhttps://www.sec.gov/Archives/edgar/data/1001316/000114036119010173/0001140361-19-010173-index.htm
2020-05-29PX14A6GNotice of exempt solicitation submitted by non-managementhttps://www.sec.gov/Archives/edgar/data/1001316/000114036120012674/0001140361-20-012674-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000114420419008306/0001144204-19-008306-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266118000780/0001172661-18-000780-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266119000823/0001172661-19-000823-index.htm
2019-03-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266119000927/0001172661-19-000927-index.htm
2020-01-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266120000001/0001172661-20-000001-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266120000786/0001172661-20-000786-index.htm
2018-06-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1001316/000119312518195773/0001193125-18-195773-index.htm
2018-07-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1001316/000119312518215834/0001193125-18-215834-index.htm
2019-03-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000131924419000034/0001319244-19-000034-index.htm
2020-01-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000131924420000018/0001319244-20-000018-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1001316/000155837020001897/0001558370-20-001897-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020001925/0001558370-20-001925-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020002992/0001558370-20-002992-index.htm
2020-03-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020002997/0001558370-20-002997-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1001316/000155837020004647/0001558370-20-004647-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1001316/000155837020004651/0001558370-20-004651-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020004722/0001558370-20-004722-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020005097/0001558370-20-005097-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020006304/0001558370-20-006304-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020006314/0001558370-20-006314-index.htm
2020-05-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020006630/0001558370-20-006630-index.htm
2020-05-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020006795/0001558370-20-006795-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020006811/0001558370-20-006811-index.htm
2020-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020007744/0001558370-20-007744-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020010225/0001558370-20-010225-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020012661/0001558370-20-012661-index.htm
2018-02-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418001025/0001654954-18-001025-index.htm
2018-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418002262/0001654954-18-002262-index.htm
2018-03-1510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1001316/000165495418002638/0001654954-18-002638-index.htm
2018-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004295/0001654954-18-004295-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004519/0001654954-18-004519-index.htm
2018-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004521/0001654954-18-004521-index.htm
2018-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004821/0001654954-18-004821-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495418005046/0001654954-18-005046-index.htm
2018-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006261/0001654954-18-006261-index.htm
2018-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006381/0001654954-18-006381-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006609/0001654954-18-006609-index.htm
2018-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006703/0001654954-18-006703-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006742/0001654954-18-006742-index.htm
2018-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006743/0001654954-18-006743-index.htm
2018-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006777/0001654954-18-006777-index.htm
2018-06-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006935/0001654954-18-006935-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007116/0001654954-18-007116-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007117/0001654954-18-007117-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007118/0001654954-18-007118-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007119/0001654954-18-007119-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007120/0001654954-18-007120-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007121/0001654954-18-007121-index.htm
2018-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007267/0001654954-18-007267-index.htm
2018-07-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm
2018-07-09S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1001316/000165495418007460/0001654954-18-007460-index.htm
2018-07-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007816/0001654954-18-007816-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418008559/0001654954-18-008559-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495418008750/0001654954-18-008750-index.htm
2018-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418010436/0001654954-18-010436-index.htm
2018-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418011171/0001654954-18-011171-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418012263/0001654954-18-012263-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495418012303/0001654954-18-012303-index.htm
2018-12-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418013524/0001654954-18-013524-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419000085/0001654954-19-000085-index.htm
2019-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419000641/0001654954-19-000641-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419002047/0001654954-19-002047-index.htm
2019-02-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419002091/0001654954-19-002091-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1001316/000165495419002189/0001654954-19-002189-index.htm
2019-03-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419002274/0001654954-19-002274-index.htm
2019-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419002276/0001654954-19-002276-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419003766/0001654954-19-003766-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005036/0001654954-19-005036-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005037/0001654954-19-005037-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005419/0001654954-19-005419-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005592/0001654954-19-005592-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419005680/0001654954-19-005680-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007297/0001654954-19-007297-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007359/0001654954-19-007359-index.htm
2019-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007706/0001654954-19-007706-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007935/0001654954-19-007935-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419009109/0001654954-19-009109-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419009176/0001654954-19-009176-index.htm
2019-08-30S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1001316/000165495419010203/0001654954-19-010203-index.htm
2019-09-05RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010400/0001654954-19-010400-index.htm
2019-09-05S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010402/0001654954-19-010402-index.htm
2019-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010620/0001654954-19-010620-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010885/0001654954-19-010885-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010886/0001654954-19-010886-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010888/0001654954-19-010888-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010890/0001654954-19-010890-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010891/0001654954-19-010891-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419012023/0001654954-19-012023-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419012611/0001654954-19-012611-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419012751/0001654954-19-012751-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419013703/0001654954-19-013703-index.htm
2019-12-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419014167/0001654954-19-014167-index.htm
2019-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419014209/0001654954-19-014209-index.htm
2018-07-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1001316/999999999518001856/9999999995-18-001856-index.htm
2018-04-30CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1001316/999999999718005345/9999999997-18-005345-index.htm
2018-09-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1001316/999999999718007926/9999999997-18-007926-index.htm

TG Therapeutics, Inc (TGTX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of TG Therapeutics, Inc (TGTX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 713%
Institutional Ownership: 6724%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-17WILLIAM JAMES KENNEDYDirectorBuy27,048.00102,378.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010886/0001654954-19-010886-index.htm
2020-06-22WILLIAM JAMES KENNEDYDirectorBuy15,000.00109,633.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm
2018-06-26MICHAEL S WEISSCEO and PresidentBuy1,018,011.0011,648,805.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007119/0001654954-18-007119-index.htm
2018-06-26Kenneth HobermanDirectorBuy15,000.00116,905.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007121/0001654954-18-007121-index.htm
2018-06-26Yann EchelardDirectorBuy15,000.00117,068.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007116/0001654954-18-007116-index.htm
2018-06-26Laurence N CharneyDirectorBuy15,000.00118,949.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007267/0001654954-18-007267-index.htm
2019-09-17DANIEL HUMEDirectorBuy27,048.00119,507.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010885/0001654954-19-010885-index.htm
2018-06-26MARK SCHOENEBAUMDirectorBuy15,000.00125,949.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007117/0001654954-18-007117-index.htm
2020-09-09RA CAPITAL MANAGEMENT, L.P.10% Share HolderSell158,589.0025.814,092,738.0412,629,868.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920104436/0001104659-20-104436-index.htm
2019-06-13MICHAEL S WEISSCEO and PresidentBuy1,179,380.0012,828,185.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419007359/0001654954-19-007359-index.htm
2019-06-26MICHAEL S WEISSCEO and PresidentBuy50,000.007.04351,750.0012,878,185.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419007706/0001654954-19-007706-index.htm
2020-06-22DANIEL HUMEDirectorBuy15,000.00134,507.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076546/0001104659-20-076546-index.htm
2019-09-17Kenneth HobermanDirectorBuy27,048.00143,953.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010891/0001654954-19-010891-index.htm
2019-09-17Yann EchelardDirectorBuy27,048.00144,116.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010888/0001654954-19-010888-index.htm
2020-06-22MICHAEL S WEISSCEO and PresidentBuy1,556,029.0014,434,214.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076547/0001104659-20-076547-index.htm
2019-09-17Laurence N CharneyDirectorBuy27,048.00145,997.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010890/0001654954-19-010890-index.htm
2020-06-22Kenneth HobermanDirectorBuy15,000.00158,953.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076545/0001104659-20-076545-index.htm
2020-06-22Yann EchelardDirectorBuy15,000.00159,116.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076544/0001104659-20-076544-index.htm
2020-06-22Laurence N CharneyDirectorBuy15,000.00160,997.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076543/0001104659-20-076543-index.htm
2019-07-01Sean A PowerCFO, Secretary and TreasurerSell17,654.008.47149,529.38383,338.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419007935/0001654954-19-007935-index.htm
2019-01-02Sean A PowerCFO, Secretary and TreasurerSell37,275.004.13153,945.75400,992.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419000085/0001654954-19-000085-index.htm
2020-07-16Sean A PowerCFO, Secretary and TreasurerBuy50,000.00433,338.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm
2018-07-03Sean A PowerCFO, Secretary and TreasurerSell35,000.0013.19461,650.00438,267.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm
2018-07-02Sean A PowerCFO, Secretary and TreasurerSell12,191.0013.26161,652.66473,267.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm
2018-06-14WILLIAM JAMES KENNEDYDirectorSell25,071.0013.45337,204.9560,330.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418006742/0001654954-18-006742-index.htm
2020-07-16Sean A PowerCFO, Secretary and TreasurerBuy200,000.00633,338.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm
2020-06-22Sagar LonialDirectorBuy65,000.0065,000.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm
2018-06-26WILLIAM JAMES KENNEDYDirectorBuy15,000.0075,330.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007120/0001654954-18-007120-index.htm
2018-06-26DANIEL HUMEDirectorBuy15,000.0092,459.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007118/0001654954-18-007118-index.htm
2020-06-17WILLIAM JAMES KENNEDYDirectorSell7,745.0018.27141,501.1594,633.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm